Genoskin
Contract Research Organisation (CRO) developing ex vivo human skin platforms capable of testing injected drugs and implanted medical devices
Genoskin has raised €7.3M across 1 funding round from 8 investors, most recently a round in Sep 2025. Based in Toulouse, France; active in Healthtech. Data as of 28 Oct 2026.
Toulouse, Francegenoskin.com ↗
Total raised
€7.3M
€7,349,835
Funding rounds
1
Investors
8
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearGenoskin — funding by year — interactive chart.
Data table
| Genoskin — funding by year | |
|---|---|
| 2025 | €7.3M |
Signals
High confidenceRaise-next likelihood42
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-17 | Other | €7.3M | BNP Paribas,Bpifrance,CA Toulouse 31 Initiatives,Caisse d’Epargne Midi-Pyrénées,Captech Santé,Credit Agricole+2 more | View deal → |
Investors
8Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData